COSTA MESA, Calif., July 18, 2014 /PRNewswire-iReach/ -- WCCT Global, a full service CRO headquartered in Southern California announced today that Lani Clark, MD, has joined WCCT Global as Head of Dermatology Clinical Research. Dr. Clark is certified by the American Board of Dermatology and is a member of the American Academy of Dermatology and the American College of Mohs surgery . She joins the organization with experience in surgery for melanoma and other skin cancers, skin tumors, moles, and cosmetic eyelid surgery. Dr. Clark also has cosmetic surgical experience in the areas of skin rejuvenation and wrinkle treatment including laser surgery, Thermage, Botox treatment, dermal fillers, and chemical peels. With Dr. Clark joining WCCT Global, they continue to expand their service offering for sponsors that have expressed the need for Investigators experienced in dermatology clinical research. WCCT Global's COO Jon Rojas stated, " We are pleased to have Dr. Clark lead our dermatology clinical research program and allow WCCT Global to offer innovative solutions for dermatology clinical research to sponsors involved in dermatology treatment R & D." With Dr. Clark joining the organization, WCCT Global continues to expand and diversify services which can be offered to our Pharma and Device R&D sponsors.
More about WCCT Global:
WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, "With compassion for people, we strive for tomorrow's therapies to be available today" truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
If you would like to request information about how WCCT Global can assist your organization with a clinical study, please CLICK HERE
Media Contact: Matt Miller, WCCT Global, 714.668.1500 ext.2029, Matt.Miller@wcct.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE WCCT Global